Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis

Emerging evidence indicates that various functional genes with altered expression are involved in the tumor progression of human cancers. This study is aimed at identifying novel key genes that may be used for hepatocellular carcinoma (HCC) diagnosis, prognosis, and targeted therapy. This study incl...

Full description

Saved in:
Bibliographic Details
Main Authors: Meng Wang, Licheng Wang, Shusheng Wu, Dongsheng Zhou, Xianming Wang
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:International Journal of Genomics
Online Access:http://dx.doi.org/10.1155/2019/3518378
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558071386210304
author Meng Wang
Licheng Wang
Shusheng Wu
Dongsheng Zhou
Xianming Wang
author_facet Meng Wang
Licheng Wang
Shusheng Wu
Dongsheng Zhou
Xianming Wang
author_sort Meng Wang
collection DOAJ
description Emerging evidence indicates that various functional genes with altered expression are involved in the tumor progression of human cancers. This study is aimed at identifying novel key genes that may be used for hepatocellular carcinoma (HCC) diagnosis, prognosis, and targeted therapy. This study included 3 expression profiles (GSE45267, GSE74656, and GSE84402), which were obtained from the Gene Expression Omnibus (GEO). GEO2R was used to analyze the differentially expressed genes (DEGs) between HCC and normal samples. The functional and pathway enrichment analysis was performed by the Database for Annotation, Visualization and Integrated Discovery. A protein-protein interaction (PPI) network of the identified DEGs was constructed using the Search Tool for the Retrieval of Interacting Gene, and hub genes were identified. ONCOMINE and CCLE databases were used to verify the expression of the hub genes in HCC tissues and cells. Kaplan-Meier plotter was used to assess the effects of the hub genes on the overall survival of HCC patients. A total of 99 DEGs were identified from the 3 expression profiles. These DEGs were enriched with functional processes and pathways related to HCC pathogenesis. From the PPI network, 5 hub genes were identified. The expression of the 5 hub genes was all upregulated in HCC tissues and cells compared with the control tissues and cells. Kaplan-Meier survival curves indicated that high expression of cyclin-dependent kinase (CDK1), cyclin B1 (CCNB1), cyclin B2 (CCNB2), MAD2 mitotic arrest deficient-like 1 (MAD2L1), and topoisomerase IIα (TOP2A) predicted poor overall survival in HCC patients (all log-rank P<0.01). These results revealed that the DEGs may serve as candidate key genes during HCC pathogenesis. The 5 hub genes, including CDK1, CCNB1, CCNB2, MAD2L1, and TOP2A, may serve as promising prognostic biomarkers in HCC.
format Article
id doaj-art-edbf5eafad174ec6b7c2b64c0bfea096
institution Kabale University
issn 2314-436X
2314-4378
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series International Journal of Genomics
spelling doaj-art-edbf5eafad174ec6b7c2b64c0bfea0962025-02-03T01:33:29ZengWileyInternational Journal of Genomics2314-436X2314-43782019-01-01201910.1155/2019/35183783518378Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics AnalysisMeng Wang0Licheng Wang1Shusheng Wu2Dongsheng Zhou3Xianming Wang4General Surgery Department, Ward 3, Central Hospital of Zi Bo, Shandong 255000, ChinaDepartment of Urology, Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, ChinaDepartment of General Surgery, Shandong Provincial Qianfoshan Hospital, Shandong University, Shandong 250014, ChinaDepartment of General Surgery, Shandong Provincial Qianfoshan Hospital, Shandong University, Shandong 250014, ChinaDepartment of General Surgery, Shandong Provincial Qianfoshan Hospital, Shandong University, Shandong 250014, ChinaEmerging evidence indicates that various functional genes with altered expression are involved in the tumor progression of human cancers. This study is aimed at identifying novel key genes that may be used for hepatocellular carcinoma (HCC) diagnosis, prognosis, and targeted therapy. This study included 3 expression profiles (GSE45267, GSE74656, and GSE84402), which were obtained from the Gene Expression Omnibus (GEO). GEO2R was used to analyze the differentially expressed genes (DEGs) between HCC and normal samples. The functional and pathway enrichment analysis was performed by the Database for Annotation, Visualization and Integrated Discovery. A protein-protein interaction (PPI) network of the identified DEGs was constructed using the Search Tool for the Retrieval of Interacting Gene, and hub genes were identified. ONCOMINE and CCLE databases were used to verify the expression of the hub genes in HCC tissues and cells. Kaplan-Meier plotter was used to assess the effects of the hub genes on the overall survival of HCC patients. A total of 99 DEGs were identified from the 3 expression profiles. These DEGs were enriched with functional processes and pathways related to HCC pathogenesis. From the PPI network, 5 hub genes were identified. The expression of the 5 hub genes was all upregulated in HCC tissues and cells compared with the control tissues and cells. Kaplan-Meier survival curves indicated that high expression of cyclin-dependent kinase (CDK1), cyclin B1 (CCNB1), cyclin B2 (CCNB2), MAD2 mitotic arrest deficient-like 1 (MAD2L1), and topoisomerase IIα (TOP2A) predicted poor overall survival in HCC patients (all log-rank P<0.01). These results revealed that the DEGs may serve as candidate key genes during HCC pathogenesis. The 5 hub genes, including CDK1, CCNB1, CCNB2, MAD2L1, and TOP2A, may serve as promising prognostic biomarkers in HCC.http://dx.doi.org/10.1155/2019/3518378
spellingShingle Meng Wang
Licheng Wang
Shusheng Wu
Dongsheng Zhou
Xianming Wang
Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis
International Journal of Genomics
title Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis
title_full Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis
title_fullStr Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis
title_full_unstemmed Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis
title_short Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis
title_sort identification of key genes and prognostic value analysis in hepatocellular carcinoma by integrated bioinformatics analysis
url http://dx.doi.org/10.1155/2019/3518378
work_keys_str_mv AT mengwang identificationofkeygenesandprognosticvalueanalysisinhepatocellularcarcinomabyintegratedbioinformaticsanalysis
AT lichengwang identificationofkeygenesandprognosticvalueanalysisinhepatocellularcarcinomabyintegratedbioinformaticsanalysis
AT shushengwu identificationofkeygenesandprognosticvalueanalysisinhepatocellularcarcinomabyintegratedbioinformaticsanalysis
AT dongshengzhou identificationofkeygenesandprognosticvalueanalysisinhepatocellularcarcinomabyintegratedbioinformaticsanalysis
AT xianmingwang identificationofkeygenesandprognosticvalueanalysisinhepatocellularcarcinomabyintegratedbioinformaticsanalysis